These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 1423274

  • 1. Renal cell carcinoma and natural killer cells: studies in a novel rat model in vitro and in vivo.
    Winter BK, Wu S, Nelson AC, Pollack SB.
    Cancer Res; 1992 Nov 15; 52(22):6279-86. PubMed ID: 1423274
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
    Hillman GG, Younes E, Visscher D, Hamzavi F, Kim S, Lam JS, Montecillo EJ, Ali E, Pontes JE, Puri RK, Haas GP.
    Clin Cancer Res; 1997 Oct 15; 3(10):1799-806. PubMed ID: 9815566
    [Abstract] [Full Text] [Related]

  • 3. Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin's lymphoma severe combined immunodeficiency mouse model.
    Hernandez-Ilizaliturri FJ, Jupudy V, Ostberg J, Oflazoglu E, Huberman A, Repasky E, Czuczman MS.
    Clin Cancer Res; 2003 Dec 01; 9(16 Pt 1):5866-73. PubMed ID: 14676108
    [Abstract] [Full Text] [Related]

  • 4. Monoclonal antibody 4H12 recognizes subsets of adherent-lymphokine activated killer cells and splenic natural killer cells from pregnant and neonatal mice.
    Linnemeyer PA, Pollack SB.
    J Immunol; 1991 Jun 01; 146(11):3729-35. PubMed ID: 2033249
    [Abstract] [Full Text] [Related]

  • 5. Cytolytic activities of IL-2 activated NK cells from MMTV/v-Ha-ras transgenic oncomice during tumor progression.
    Goldfarb RH, Albertsson P, Nannmark U, Kitson RP.
    In Vivo; 1998 Jun 01; 12(6):589-92. PubMed ID: 9891221
    [Abstract] [Full Text] [Related]

  • 6. The biology of human natural killer cells.
    Whiteside TL, Herberman RB.
    Ann Ist Super Sanita; 1990 Jun 01; 26(3-4):335-48. PubMed ID: 2091502
    [Abstract] [Full Text] [Related]

  • 7. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
    Muralikrishna K, Varalakshmi C, Khar A.
    Cytokines Cell Mol Ther; 1997 Mar 01; 3(1):51-8. PubMed ID: 9287244
    [Abstract] [Full Text] [Related]

  • 8. Tumor blood supply and tumor localization by adoptively transferred IL-2 activated natural killer cells.
    Nannmark U, Hokland ME, Agger R, Christiansen M, Kjaergaard J, Goldfarb RH, Bagge U, Unger M, Johansson BR, Albertsson PA, Basse PH.
    In Vivo; 2000 Mar 01; 14(5):651-8. PubMed ID: 11125549
    [Abstract] [Full Text] [Related]

  • 9. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y, Steinherz P, Klingemann HG, Dennig D, Childs BH, McGuirk J, O'Reilly RJ.
    Clin Cancer Res; 1998 Nov 01; 4(11):2859-68. PubMed ID: 9829753
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
    Vujanovic NL, Herberman RB, Olszowy MW, Cramer DV, Salup RR, Reynolds CW, Hiserodt JC.
    Cancer Res; 1988 Feb 15; 48(4):884-90. PubMed ID: 3257412
    [Abstract] [Full Text] [Related]

  • 12. Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells.
    Rabinowich H, Vitolo D, Altarac S, Herberman RB, Whiteside TL.
    J Immunol; 1992 Jul 01; 149(1):340-9. PubMed ID: 1535088
    [Abstract] [Full Text] [Related]

  • 13. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells.
    Mulé JJ, Yang J, Shu S, Rosenberg SA.
    J Immunol; 1986 May 15; 136(10):3899-909. PubMed ID: 2871106
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Triggering of the cytotoxic activity of murine natural killer and lymphokine-activated killer cells through the NK2.1 antigen.
    Morelli L, Lemieux S.
    J Immunol; 1993 Dec 15; 151(12):6783-93. PubMed ID: 8258690
    [Abstract] [Full Text] [Related]

  • 16. Membrane-bound interleukin (IL)-15 on renal tumor cells rescues natural killer cells from IL-2 starvation-induced apoptosis.
    Wittnebel S, Da Rocha S, Giron-Michel J, Jalil A, Opolon P, Escudier B, Validire P, Khawam K, Chouaib S, Azzarone B, Caignard A.
    Cancer Res; 2007 Jun 15; 67(12):5594-9. PubMed ID: 17575122
    [Abstract] [Full Text] [Related]

  • 17. Cure of B16F10 melanoma lung metastasis in mice by chronic indomethacin therapy combined with repeated rounds of interleukin 2: characteristics of killer cells generated in situ.
    Lala PK, Parhar RS.
    Cancer Res; 1988 Mar 01; 48(5):1072-9. PubMed ID: 3124954
    [Abstract] [Full Text] [Related]

  • 18. Antitumor activities of subsets of human IL-2-activated natural killer cells in solid tissues.
    Vujanovic NL, Yasumura S, Hirabayashi H, Lin WC, Watkins S, Herberman RB, Whiteside TL.
    J Immunol; 1995 Jan 01; 154(1):281-9. PubMed ID: 7995947
    [Abstract] [Full Text] [Related]

  • 19. Regulation of natural killer cell production in bone marrow of mice: no evidence for negative feedback control.
    Bilge A, Pollack SB.
    Nat Immun; 1992 Jan 01; 11(3):156-66. PubMed ID: 1392403
    [Abstract] [Full Text] [Related]

  • 20. Assessment of human natural killer and lymphokine-activated killer cell cytotoxicity against Toxoplasma gondii trophozoites and brain cysts.
    Dannemann BR, Morris VA, Araujo FG, Remington JS.
    J Immunol; 1989 Oct 15; 143(8):2684-91. PubMed ID: 2477453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.